PuhrS, DerdzinskiM, WelshJB, et al.: Real-world hypoglycemia avoidance with a continuous glucose monitoring system's predictive low glucose alert. Diabetes Technol Ther, 2019; 21:155–158.
2.
WelshJB, GaoP, DerdzinskiM, et al.: Accuracy, utilization, effectiveness comparisons of different continuous glucose monitoring systems. Diabetes Technol Ther, 2019; 21:128–132.
3.
US FDA, Dexcom G6 Continuous glucose monitoring system indications for use. https://www.accessdata.fda.gov/cdrh_docs/pdf19/K191450.pdf Last accessed November26, 2019.
4.
ReddyM, JugneeN, El LaboudiA, et al.: A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia. Diabet Med, 2018; 35:483–490.
5.
ReddyM, JugneeN, AnantharajaS, OliverN: Switching from flash glucose monitoring to continuous glucose monitoring on hypoglycemia in adults with Type 1 diabetes at high hypoglycemia risk: the extension phase of the I HART CGM study. Diabetes Technol Ther, 2018; 20:751–757.
6.
SeiboldA, SchlaegerC: Comparison of continuous and flash glucose monitoring in Type 1 diabetes: methodological inconsistency precludes hypoglycaemia conclusions. Diabet Med, 2018; 35:1618–1619.
7.
SeiboldA: Regarding: Switching from flash glucose monitoring to continuous glucose monitoring on hypoglycemia in adults with Type 1 diabetes at high hypoglycemia risk: the Extension Phase of the I HART CGM Study-Concerns that Reduce Confidence in Conclusions regarding Hypoglycemia. Diabetes Technol Ther, 2019; 21:97–98.
8.
OliverN, ReddyM: Reply to Seibold and Schlaeger. Comparison of continuous and flash glucose monitoring in Type 1 diabetes: methodological inconsistency precludes hypoglycaemia conclusions. Diabet Med, 201835(11):1619–1620.
9.
BattellinoT, DanneT, AmielSA, et al.: Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care, 2019;pii:dci190028.
